Restoril vs. Mel: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Restoril and Mel. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 55,103 people who take Restoril and Mel, and is updated regularly.
What is Restoril?
Restoril has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 13,522 Restoril users. Check the latest studies of Restoril.
What is Mel?
Mel has active ingredients of honey. It is often used in insomnia. eHealthMe is studying from 72 Mel users. Check the latest studies of Mel.
55,103 people who take Restoril and Mel are studied.

Drugs being compared in this study:
- Mel (honey)
- Restoril (temazepam)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Restoril:
- not at all: 3.79 %
- somewhat: 25.06 %
- moderate: 34.45 %
- high: 23.0 %
- very high: 13.7 %
Mel:
- not at all: 13.27 %
- somewhat: 9.18 %
- moderate: 43.88 %
- high: 27.55 %
- very high: 6.12 %
Want to compare Restoril with Mel?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Restoril:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Mel:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on temazepam and honey (the active ingredients of Restoril and Mel, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Vivelle cause Drowsiness? - 3 seconds ago
- Medroxyprogesterone Acetate vs. Vagifem, side effect and effectiveness comparison - 16 seconds ago
- Could Ginkgo Biloba cause Mood Swings? - 20 seconds ago
- Drug interactions of Enbrel and Pseudoephedrine Hydrochloride And Triprolidine Hydrochloride - 23 seconds ago
- Could Hydroxychloroquine Sulfate cause Stroke? - 25 seconds ago
- Could Valtrex cause Gingival Hyperplasia? - 33 seconds ago
- Drug interactions of Clarithromycin and Bactrim Ds - 40 seconds ago
- Liver Disorder and Heart Rate Decreased - 40 seconds ago
- Could Viread cause Bone Lesion? - 41 seconds ago
- Hiatal Hernia and Heart Rate Decreased - 48 seconds ago